The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sacubitril Valsartan Sodium Market Research Report 2025
Synopsis
Drug for adult patients with chronic heart failure with a decrease in the ejection fraction
Global Sacubitril Valsartan Sodium market is projected to reach US$ 6042.4 million in 2029, increasing from US$ 3595 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sacubitril Valsartan Sodium market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sacubitril Valsartan Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Tianyu Pharma
Sepharma
Wisdom Pharmaceutical
Qilu Pharma
SPH
Zhongdan Group
Kelun
Rundu Pharma
Disha Pharmaceutical Group
Brilliant Pharmaceuticals
Sihuan Pharma
Salubris
Sino Biopharm
CSPC
FS Pharmatech
Novartis
Segment by Type
Original Drug
Generic Drug
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sacubitril Valsartan Sodium report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Drug for adult patients with chronic heart failure with a decrease in the ejection fraction
Global Sacubitril Valsartan Sodium market is projected to reach US$ 6042.4 million in 2029, increasing from US$ 3595 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sacubitril Valsartan Sodium market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sacubitril Valsartan Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Tianyu Pharma
Sepharma
Wisdom Pharmaceutical
Qilu Pharma
SPH
Zhongdan Group
Kelun
Rundu Pharma
Disha Pharmaceutical Group
Brilliant Pharmaceuticals
Sihuan Pharma
Salubris
Sino Biopharm
CSPC
FS Pharmatech
Novartis
Segment by Type
Original Drug
Generic Drug
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sacubitril Valsartan Sodium report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Sacubitril Valsartan Sodium Market Overview
1.1 Product Overview and Scope of Sacubitril Valsartan Sodium
1.2 Sacubitril Valsartan Sodium Segment by Type
1.2.1 Global Sacubitril Valsartan Sodium Market Value Comparison by Type (2023-2029)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Sacubitril Valsartan Sodium Segment by Application
1.3.1 Global Sacubitril Valsartan Sodium Market Value by Application: (2023-2029)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Sacubitril Valsartan Sodium Market Size Estimates and Forecasts
1.4.1 Global Sacubitril Valsartan Sodium Revenue 2018-2029
1.4.2 Global Sacubitril Valsartan Sodium Sales 2018-2029
1.4.3 Global Sacubitril Valsartan Sodium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sacubitril Valsartan Sodium Market Competition by Manufacturers
2.1 Global Sacubitril Valsartan Sodium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sacubitril Valsartan Sodium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sacubitril Valsartan Sodium Average Price by Manufacturers (2018-2023)
2.4 Global Sacubitril Valsartan Sodium Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sacubitril Valsartan Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sacubitril Valsartan Sodium, Product Type & Application
2.7 Sacubitril Valsartan Sodium Market Competitive Situation and Trends
2.7.1 Sacubitril Valsartan Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sacubitril Valsartan Sodium Players Market Share by Revenue
2.7.3 Global Sacubitril Valsartan Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sacubitril Valsartan Sodium Retrospective Market Scenario by Region
3.1 Global Sacubitril Valsartan Sodium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sacubitril Valsartan Sodium Global Sacubitril Valsartan Sodium Sales by Region: 2018-2029
3.2.1 Global Sacubitril Valsartan Sodium Sales by Region: 2018-2023
3.2.2 Global Sacubitril Valsartan Sodium Sales by Region: 2024-2029
3.3 Global Sacubitril Valsartan Sodium Global Sacubitril Valsartan Sodium Revenue by Region: 2018-2029
3.3.1 Global Sacubitril Valsartan Sodium Revenue by Region: 2018-2023
3.3.2 Global Sacubitril Valsartan Sodium Revenue by Region: 2024-2029
3.4 North America Sacubitril Valsartan Sodium Market Facts & Figures by Country
3.4.1 North America Sacubitril Valsartan Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sacubitril Valsartan Sodium Sales by Country (2018-2029)
3.4.3 North America Sacubitril Valsartan Sodium Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sacubitril Valsartan Sodium Market Facts & Figures by Country
3.5.1 Europe Sacubitril Valsartan Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sacubitril Valsartan Sodium Sales by Country (2018-2029)
3.5.3 Europe Sacubitril Valsartan Sodium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sacubitril Valsartan Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Sacubitril Valsartan Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sacubitril Valsartan Sodium Sales by Country (2018-2029)
3.6.3 Asia Pacific Sacubitril Valsartan Sodium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sacubitril Valsartan Sodium Market Facts & Figures by Country
3.7.1 Latin America Sacubitril Valsartan Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sacubitril Valsartan Sodium Sales by Country (2018-2029)
3.7.3 Latin America Sacubitril Valsartan Sodium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sacubitril Valsartan Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Sacubitril Valsartan Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sacubitril Valsartan Sodium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sacubitril Valsartan Sodium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sacubitril Valsartan Sodium Sales by Type (2018-2029)
4.1.1 Global Sacubitril Valsartan Sodium Sales by Type (2018-2023)
4.1.2 Global Sacubitril Valsartan Sodium Sales by Type (2024-2029)
4.1.3 Global Sacubitril Valsartan Sodium Sales Market Share by Type (2018-2029)
4.2 Global Sacubitril Valsartan Sodium Revenue by Type (2018-2029)
4.2.1 Global Sacubitril Valsartan Sodium Revenue by Type (2018-2023)
4.2.2 Global Sacubitril Valsartan Sodium Revenue by Type (2024-2029)
4.2.3 Global Sacubitril Valsartan Sodium Revenue Market Share by Type (2018-2029)
4.3 Global Sacubitril Valsartan Sodium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sacubitril Valsartan Sodium Sales by Application (2018-2029)
5.1.1 Global Sacubitril Valsartan Sodium Sales by Application (2018-2023)
5.1.2 Global Sacubitril Valsartan Sodium Sales by Application (2024-2029)
5.1.3 Global Sacubitril Valsartan Sodium Sales Market Share by Application (2018-2029)
5.2 Global Sacubitril Valsartan Sodium Revenue by Application (2018-2029)
5.2.1 Global Sacubitril Valsartan Sodium Revenue by Application (2018-2023)
5.2.2 Global Sacubitril Valsartan Sodium Revenue by Application (2024-2029)
5.2.3 Global Sacubitril Valsartan Sodium Revenue Market Share by Application (2018-2029)
5.3 Global Sacubitril Valsartan Sodium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Tianyu Pharma
6.1.1 Tianyu Pharma Corporation Information
6.1.2 Tianyu Pharma Description and Business Overview
6.1.3 Tianyu Pharma Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Tianyu Pharma Sacubitril Valsartan Sodium Product Portfolio
6.1.5 Tianyu Pharma Recent Developments/Updates
6.2 Sepharma
6.2.1 Sepharma Corporation Information
6.2.2 Sepharma Description and Business Overview
6.2.3 Sepharma Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sepharma Sacubitril Valsartan Sodium Product Portfolio
6.2.5 Sepharma Recent Developments/Updates
6.3 Wisdom Pharmaceutical
6.3.1 Wisdom Pharmaceutical Corporation Information
6.3.2 Wisdom Pharmaceutical Description and Business Overview
6.3.3 Wisdom Pharmaceutical Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Wisdom Pharmaceutical Sacubitril Valsartan Sodium Product Portfolio
6.3.5 Wisdom Pharmaceutical Recent Developments/Updates
6.4 Qilu Pharma
6.4.1 Qilu Pharma Corporation Information
6.4.2 Qilu Pharma Description and Business Overview
6.4.3 Qilu Pharma Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qilu Pharma Sacubitril Valsartan Sodium Product Portfolio
6.4.5 Qilu Pharma Recent Developments/Updates
6.5 SPH
6.5.1 SPH Corporation Information
6.5.2 SPH Description and Business Overview
6.5.3 SPH Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 SPH Sacubitril Valsartan Sodium Product Portfolio
6.5.5 SPH Recent Developments/Updates
6.6 Zhongdan Group
6.6.1 Zhongdan Group Corporation Information
6.6.2 Zhongdan Group Description and Business Overview
6.6.3 Zhongdan Group Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhongdan Group Sacubitril Valsartan Sodium Product Portfolio
6.6.5 Zhongdan Group Recent Developments/Updates
6.7 Kelun
6.6.1 Kelun Corporation Information
6.6.2 Kelun Description and Business Overview
6.6.3 Kelun Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kelun Sacubitril Valsartan Sodium Product Portfolio
6.7.5 Kelun Recent Developments/Updates
6.8 Rundu Pharma
6.8.1 Rundu Pharma Corporation Information
6.8.2 Rundu Pharma Description and Business Overview
6.8.3 Rundu Pharma Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Rundu Pharma Sacubitril Valsartan Sodium Product Portfolio
6.8.5 Rundu Pharma Recent Developments/Updates
6.9 Disha Pharmaceutical Group
6.9.1 Disha Pharmaceutical Group Corporation Information
6.9.2 Disha Pharmaceutical Group Description and Business Overview
6.9.3 Disha Pharmaceutical Group Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Disha Pharmaceutical Group Sacubitril Valsartan Sodium Product Portfolio
6.9.5 Disha Pharmaceutical Group Recent Developments/Updates
6.10 Brilliant Pharmaceuticals
6.10.1 Brilliant Pharmaceuticals Corporation Information
6.10.2 Brilliant Pharmaceuticals Description and Business Overview
6.10.3 Brilliant Pharmaceuticals Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Brilliant Pharmaceuticals Sacubitril Valsartan Sodium Product Portfolio
6.10.5 Brilliant Pharmaceuticals Recent Developments/Updates
6.11 Sihuan Pharma
6.11.1 Sihuan Pharma Corporation Information
6.11.2 Sihuan Pharma Sacubitril Valsartan Sodium Description and Business Overview
6.11.3 Sihuan Pharma Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sihuan Pharma Sacubitril Valsartan Sodium Product Portfolio
6.11.5 Sihuan Pharma Recent Developments/Updates
6.12 Salubris
6.12.1 Salubris Corporation Information
6.12.2 Salubris Sacubitril Valsartan Sodium Description and Business Overview
6.12.3 Salubris Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Salubris Sacubitril Valsartan Sodium Product Portfolio
6.12.5 Salubris Recent Developments/Updates
6.13 Sino Biopharm
6.13.1 Sino Biopharm Corporation Information
6.13.2 Sino Biopharm Sacubitril Valsartan Sodium Description and Business Overview
6.13.3 Sino Biopharm Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sino Biopharm Sacubitril Valsartan Sodium Product Portfolio
6.13.5 Sino Biopharm Recent Developments/Updates
6.14 CSPC
6.14.1 CSPC Corporation Information
6.14.2 CSPC Sacubitril Valsartan Sodium Description and Business Overview
6.14.3 CSPC Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CSPC Sacubitril Valsartan Sodium Product Portfolio
6.14.5 CSPC Recent Developments/Updates
6.15 FS Pharmatech
6.15.1 FS Pharmatech Corporation Information
6.15.2 FS Pharmatech Sacubitril Valsartan Sodium Description and Business Overview
6.15.3 FS Pharmatech Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 FS Pharmatech Sacubitril Valsartan Sodium Product Portfolio
6.15.5 FS Pharmatech Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Sacubitril Valsartan Sodium Description and Business Overview
6.16.3 Novartis Sacubitril Valsartan Sodium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Novartis Sacubitril Valsartan Sodium Product Portfolio
6.16.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sacubitril Valsartan Sodium Industry Chain Analysis
7.2 Sacubitril Valsartan Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sacubitril Valsartan Sodium Production Mode & Process
7.4 Sacubitril Valsartan Sodium Sales and Marketing
7.4.1 Sacubitril Valsartan Sodium Sales Channels
7.4.2 Sacubitril Valsartan Sodium Distributors
7.5 Sacubitril Valsartan Sodium Customers
8 Sacubitril Valsartan Sodium Market Dynamics
8.1 Sacubitril Valsartan Sodium Industry Trends
8.2 Sacubitril Valsartan Sodium Market Drivers
8.3 Sacubitril Valsartan Sodium Market Challenges
8.4 Sacubitril Valsartan Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
